A 2023 University College London study published in the British Medical Journal Medicine analyzed National Health Service genomic and disease data and found that polygenic risk scores—the sum of all genetic association scores for disease—have very weak predictive power, correctly predicting disease in some cases but incorrectly predicting disease in many others, at a level that would not meet regulatory standards for pharmaceutical approval.
factualpending
Speaker
Dennis NobleEvidence Quote
“[57:38] 'the correlation is very weak'”
Created: 8/11/2026, 6:58:23 AM
Your notes
Loading notes...